Heparin-bonded catheters for prolonging the patency of central venous catheters in children

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 2, 2014, Pages

  Shah, Prakeshkumar S ^a   Shah, Niketa ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b New Jersey Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETER INFECTION; CATHETER OCCLUSION; CATHETER THROMBOSIS; CLINICAL EFFECTIVENESS; HUMAN; OPERATION DURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME; ADOLESCENT; CENTRAL VENOUS CATHETERIZATION; CHILD; EQUIPMENT; INFANT; META ANALYSIS; NEWBORN; PRESCHOOL CHILD; VEIN THROMBOSIS;

ANTICOAGULANT AGENT; HEPARIN;

ADOLESCENT; ANTICOAGULANTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; HEPARIN; HUMANS; INFANT; INFANT, NEWBORN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VENOUS THROMBOSIS;

EID: 84907662060     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005983.pub3     Document Type: Review

References (32)

1. Anton N, Cox P, Massicotte P, Dinyari M, Vegh P, Mitchell LG. No difference in incidences of thrombosis between heparin bonded catheters and non heparin bonded catheters in Infants in the critical care unit following surgery for congenital heart disease: a randomised controlled triple blind study. Journal of Thrombosis and Haemostasis 2005;3:Abstract P1726.
2. Anton N, Cox PN, Massicotte MP, Chait P, Yasui Y, Dinyari PM, et al.Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics 2009;123(3):e453-8.
3. Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Medicine 2000;26(7):967-72.
4. Appelgren P, Ransjo U, Bindslev L, Espersen F, Larm O. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Critical Care Medicine 1996;24(9):1482-9.
5. Bennegard K, Curelaru I, Gustavsson B, Linder LE, Zachrisson BF. Material thrombogenicity in central venous catheterization. I. A comparison between uncoated and heparin-coated, long antebrachial, polyethylene catheters. Acta Anaesthesiologica Scandinavica 1982;26(2):112-20.
6. Carrasco MN, Bueno A, de las Cuevas C, Jimenez S, Salinas I, Sartorius A, et al.Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Medicine 2004;30(4):633-8.
7. Hitz F, Klingbiel D, Omlin A, Riniker S, Zerz A, Cerny T. Athrombogenic coating of long-term venous catheter for cancer patients: a prospective, randomised, double-blind trial. Annals of Hematology 2012;91(4):613-20.
8. Hoar PF, Wilson RM, Mangano DT, Avery GJ, Szarnicki RJ, Hill JD. Heparin bonding reduces thrombogenicity of pulmonary-artery catheters. New England Journal of Medicine 1981;305(17):993-5.
9. Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM. Catheter-related thrombosis in critically ill children: Comparison of catheters with and without heparin bonding. Journal of Pediatrics 1995;126(1):50-4.
10. Mangano DT. Heparin bonding and long-term protection against thrombogenesis. New England Journal of Medicine 1982;307(14):894-5.
11. Abdelkefi A, Ben Othman T, Kammoun L, Chelli M, Romdhane NB, Kriaa A, et al.Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial. Thrombosis and Haemostasis 2004;92(3):654-61.
12. Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, et al.Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994;83(5):1251-7.
13. Bailey MJ. Reduction of catheter-associated sepsis in parenteral nutrition using low-dose intravenous heparin. British Medical Journal 1979;1(6179):1671-3.
14. Beck C, Dubois J, Grignon A, Lacroix J, David M. Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: a prospective study. Journal of Pediatrics 1998;133(2):237-41.
15. Brismar B, Hardstedt C, Jacobson S, Kager L, Malmborg AS. Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapy. Archives of Surgery 1982;117(9):1196-9.
16. de Neef M, Heijboer H, van Woensel JB, de Haan RJ. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial. Pediatric Hematology and Oncology 2002;19(8):553-60.
17. Di Costanzo J, Sastre B, Choux R, Reynier JP, Noirclerc M, Cano N, et al.Experimental approach to prevention of catheter-related central venous thrombosis. Journal of Parenteral and Enteral Nutrition 1984;8(3):293-7.
18. Gilbert R, Howard R, Mok Q. Heparin-bonded lines reduce hospital-acquired bacteraemia. Journal of Hospital Infection 2003;54(2):163-4.
19. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available from www.cochrane-handbook.org.
20. Hofbauer R, Moser D, Kaye AD, Dielacher C, Hornykewycz S, Handler S, et al.Thrombus formation on the balloon of heparin-bonded pulmonary artery catheters: an ultrastructural scanning electron microscope study. Critical Care Medicine 2000;28(3):727-35.
21. Jacobs BR, Barr LL, Brilli RJ, Lyons KA, Wong HR. Intracatheter nitroglycerin infusion fails to prevent catheter-related venous thrombosis: a randomized, controlled trial. Intensive Care Medicine 2001;27(1):187-92.
22. Klerk CP, Smorenburg SM, Buller HR. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Archives of Internal Medicine 2003;163(16):1913-21.
23. Marin MG, Lee JC, Skurnick JH. Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters. Critical Care Medicine 2000;28(9):3332-8.
24. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. Journal of Pediatrics 1998;133(6):770-6.
25. Mollenholt P, Eriksson I, Andersson T. Thrombogenicity of pulmonary-artery catheters. Intensive Care Medicine 1987;13(1):57-9.
26. Nichols AB, Owen J, Grossman BA, Marcella JJ, Fleisher LN, Lee MM. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation. Circulation 1984;70(5):843-50.
27. Rabe C, Gramann T, Sons X, Berna M, Gonzalez-Carmona MA, Klehr HU, et al.Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Medicine 2002;28(8):1172-6.
28. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 1998;113(1):165-71.
29. Schmugge M, Risch L, Huber AR, Benn A, Fischer JE. Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics 2002;109(1):E10.
30. Timsit JF, Farkas JC, Boyer JM, Martin JB, Misset B, Renaud B, et al.Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 1998;114(1):207-13.
31. Warkentin TE, Kelton JG. Heparin and platelets. Hematology -Oncology Clinics of North America 1990;4(1):243-64.
32. Shah PS, Shah N. Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD005983.pub2]